Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LUNGPOINT PROCEDURE PLANNING

K-Number: K093423 · 2009-11-17

ApplicantBroncus Technologies, Inc.
Decision Date2009-11-17
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

LUNGPOINT PROCEDURE PLANNING is the device name listed in this FDA 510(k) record. The listed applicant is Broncus Technologies, Inc.. It received FDA 510(k) clearance on 2009-11-17 under 510(k) number K093423. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LUNGPOINT PROCEDURE PLANNING?

LUNGPOINT PROCEDURE PLANNING is a medical device that received FDA 510(k) clearance on 2009-11-17. The listed applicant is Broncus Technologies, Inc.. The 510(k) number is K093423.

When did LUNGPOINT PROCEDURE PLANNING receive FDA 510(k) clearance?

LUNGPOINT PROCEDURE PLANNING received FDA 510(k) clearance on 2009-11-17, under 510(k) number K093423.

Who is the listed applicant for LUNGPOINT PROCEDURE PLANNING?

The FDA 510(k) record lists Broncus Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LUNGPOINT PROCEDURE PLANNING?

The FDA product code for LUNGPOINT PROCEDURE PLANNING is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Broncus Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K112051LUNGPOINT PLANNING AND VIRTUAL BRONCHOSCOPIC NAVIGATION (VBN) SOFTWAREK091160LUNGPOINT VIRTUAL BRONCHOSCOPIC NAVIGATION VBN SYSTEMK090853YIELD TISSUE SAMPLERK090743YIELD MINI DOPPLER SYSTEMK090095LUNGPOINT VIRTUAL BRONCHOSCOPIC NAVIGATION VBN SYSTEMK013111EXHALE PROBE

View all 11 devices →

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261874Syneris PACS v.1.0.1.0SynerisK262442HipStudio AnalysisReplasia BVK261855Elucid PlaqueIQElucid Bioimaging, Inc.K254214OOOPDSTaiwan Main Orthopaedic Biotechnology Co., Ltd.K261861SPINEsim v1.0Mdsim S.A.K2620603D-RD-SRadiopharmaceutical Imaging & Dosimetry, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑